Found: 11
Select item for more details and to access through your institution.
Phenotypic characterization of disease‐initiating stem cells in JAK2‐ or CALR‐mutated myeloproliferative neoplasms.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 5, p. 770, doi. 10.1002/ajh.26889
- By:
- Publication type:
- Article
BRD4 degradation blocks expression of MYC and multiple forms of stem cell resistance in Ph<sup>+</sup> chronic myeloid leukemia.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 9, p. 1215, doi. 10.1002/ajh.26650
- By:
- Publication type:
- Article
Coronavirus Receptor Expression Profiles in Human Mast Cells, Basophils, and Eosinophils.
- Published in:
- Cells (2073-4409), 2024, v. 13, n. 2, p. 173, doi. 10.3390/cells13020173
- By:
- Publication type:
- Article
Identification of CD203c as a New Basophil-Specific Flow-Marker in Ph + Chronic Myeloid Leukemia.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 1, p. 3, doi. 10.3390/cells12010003
- By:
- Publication type:
- Article
Immunotherapy-Based Targeting and Elimination of Leukemic Stem Cells in AML and CML.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 17, p. 4233, doi. 10.3390/ijms20174233
- By:
- Publication type:
- Article
Eosinophils and eosinophil-associated disorders: immunological, clinical, and molecular complexity.
- Published in:
- Seminars in Immunopathology, 2021, v. 43, n. 3, p. 423, doi. 10.1007/s00281-021-00863-y
- By:
- Publication type:
- Article
DPPIV (CD26) as a novel stem cell marker in Ph+ chronic myeloid leukaemia.
- Published in:
- European Journal of Clinical Investigation, 2014, v. 44, n. 12, p. 1239, doi. 10.1111/eci.12368
- By:
- Publication type:
- Article
Cell‐based and antibody‐mediated immunotherapies directed against leukemic stem cells in acute myeloid leukemia: Perspectives and open issues.
- Published in:
- Stem Cells Translational Medicine, 2020, v. 9, n. 11, p. 1331, doi. 10.1002/sctm.20-0147
- By:
- Publication type:
- Article
CDK4/CDK6 Inhibitors Synergize with Midostaurin, Avapritinib, and Nintedanib in Inducing Growth Inhibition in KIT D816V + Neoplastic Mast Cells.
- Published in:
- Cancers, 2022, v. 14, n. 13, p. N.PAG, doi. 10.3390/cancers14133070
- By:
- Publication type:
- Article
What are the challenges in 2016 regarding resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and cancer?
- Published in:
- 2017
- By:
- Publication type:
- journal article
Cancer stem cells in basic science and in translational oncology: can we translate into clinical application?
- Published in:
- Journal of Hematology & Oncology, 2015, v. 8, n. 1, p. 1, doi. 10.1186/s13045-015-0113-9
- By:
- Publication type:
- Article